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INTRODUCTION
Breast cancer is the most common cancer in women world-
wide regardless of the countries’ level of development (1).
Among Korean women, breast was the second most com-
mon cancer site following stomach in year 2001 (2). How-
ever, in 2002, it became the most common form of sporadic
cancer in Korean women and comprised 16.8% of all female
cancers (3). The Korean Ministry of Health and Welfare start-
ed a nationwide, hospital-based cancer registry called the
Korea Central Cancer Registry (KCCR) in 1980. Details of
the history, objectives, and activities of the KCCR were doc-
umented previously (3). In 1996, the Korea Breast Cancer
Society (KBCS) initiated breast cancer on-line registration (4),
which has been collecting data on breast cancer cases includ-
ing stage information. The KCCR has been collaborating
with the KBCS to improve completeness and validity of
breast cancer registration. Breast cancer cases registered by
the KCCR were merged with the cases registered by the
KBCS. Also, through using data from 8 regional cancer reg-
istries and other sources including mortality data from the
National Statistical Office (NSO), it became possible to pro-
duce national cancer statistics of Korea (2). In this paper, we
present the trends of breast cancer incidence and mortality
rates and the overall and stage-specific survival of breast can-
cer during 1993 and 2002 in Korea.
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Population-based Breast Cancer Statistics in Korea during 1993-2002:
Incidence, Mortality, and Survival
In 2002, breast became the most common cancer site in Korean women. Using
national breast cancer incidence data during 1993-2002, crude, age-standardized,
and age-specific rates for incidence and mortality were calculated. Survival was
examined for cases diagnosed during 1993-2002 and followed up to 2004. Observ-
ed survival was calculated using the life table method and relative survival using
the Ederer II method. Age-standardized incidence rates in female increased from
14.5 in 1993 to 26.2 per 100,000 in 2002. Age-specific incidences showed peaks in
women in their forties. Mortality rates increased from 3.7 in 1993 to 4.6 per 100,000
in 2002 and showed peaks in women in their fifties. Five-year relative survival for
female breast cancer diagnosed during 1993-2002 was 82.2%. When we exam-
ined the secular trends using cases diagnosed 1993-1999 for complete 5-yr follow-
up, the 5-yr relative survival increased from 75.2% in 1993 to 83.5% in 1999. The
data from this study will provide valuable information to plan and evaluate actions
against breast cancer including national breast cancer screening.
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MATERIALS AND METHODS
Data sources
The breast cancer incidence database (DB) was derived
from the Korea National Cancer Incidence Data Bases (KN-
CIDB), which were prepared by merging the KCCR mother
DB, the population-based regional cancer registry (PB-RCR)
DBs, the data from the ad hoc medical record review survey,
cancer claims DB for newly diagnosed from the National
Health Insurance Corporation (NHIC), the KBCS databases
registered by surgeons and mortality data from the NSO for
identifying the Death Certificate Only (DCO) cases and cal-
culating mortality rates. In addition, information about car-
cinoma in situ (CIS) was ascertained from the KBCS regis-
tration.
Incidence
A total of 49,964 invasive breast cancer (ICD-9 code 174
for women and 175 for men; ICD-10 code C50) cases (49,558
women and 406 men) and 2,999 CIS cases (2,984 women
and 15 men) were included for calculating incidence rates
(Table 1). In this report, the denominator is the mid-year
population annually released from the NSO (5). Crude inci-
dence rates per 100,000 were calculated, and age-specific
rates were calculated for 17 age groups (0-4, 5-9, every five
year, 80 yr and over). All the rates were standardized to the
WHO world standard population (6). Changes in the annu-
al age-standardized breast cancer incidence rates were exam-
ined by calculating the average annual percentage change
(APC) over a time period. For this, we used the Korea 2000
population as a standard population (5). The APC is 100 (e
-1), where  is the slope from a regression of log age-standard-
ized rates on calendar year (7). We calculated several indices
of quality for incidence data registered; mortality:incidence
ratio (M:I ratio), proportions of DCO, microscopically veri-
fied cases (MV%), and age-unknown cases (Age UNK%).
For mortality:incidence ratio (M:I), an indicator of data com-
pleteness, the mortality data on cancer during the same peri-
od as the registered cases from the NSO were compared to the
incidence data from the registry, which was presented in per-
cent. DCO%, percentage of cases that are registered on the
basis of death certificates only, is one of the indices of validi-
ty of diagnosis. The MV%, an indicator of the validity of the
diagnostic information, is the percentage of cases for which
the diagnosis was based on morphological verification of a
tissue specimen.
Mortality
Crude and age-standardized mortality rates were calculat-
ed using the cases whose cause of death was breast cancer in
NSO DB as a numerator and the mid-year population as a
denominator. The average APC for mortality rates was also
examined by the same method used for incidence rates.
Survival
Survival rates were examined for 46,985 female breast can-
cer cases first diagnosed during 1993-2002 and followed up
for vital status through 31 December, 2004. Among 49,558
invasive cases, a total of 2,573 cases (5.2%) were excluded
from the analysis; 1,786 DCO cases (3.6%) due to unverifi-
able date of diagnosis; 787 (1.6%) cases due to other errors
related with stage and mismatched Personal Identification
Number (PIN). The survival duration of each case was deter-
mined as the time difference (in months) between the date of
initial diagnosis until the date of death, date of loss to follow-
up, or the closing date for follow-up. To adjust for the effect
Year
Female
Incidence* DCO
(B)
Invasive
cases
(A)
CIS
(Cases)
CIS
(Cases)
Deaths
(Per-
son)
Morta-
lity
�
CR
Deaths
(Person)
Mortality
�
CR
ASR ASR
CR ASR
Male
Incidence* DCO
(B)
Invasive
cases
(A) CR ASR
1993 3,308 327 14.8 14.5 129 838 3.8 3.7 42 2 0.2 0.2 1 6 0.03 0.04
1994 3,304 270 14.7 14.1 112 833 3.7 3.6 32 2 0.1 0.2 0 8 0.04 0.06
1995 3,447 252 15.2 14.1 118 907 4.0 3.8 25 8 0.1 0.1 1 16 0.07 0.09
1996 4,094 223 17.9 16.4 153 991 4.3 4.0 30 7 0.1 0.2 1 14 0.06 0.09
1997 4,528 184 19.6 17.6 205 976 4.2 3.8 49 6 0.2 0.3 1 12 0.05 0.07
1998 4,775 155 20.5 18.0 305 994 4.3 3.8 33 10 0.1 0.2 1 16 0.07 0.07
1999 5,641 110 24.0 20.7 374 1,133 4.8 4.2 41 4 0.2 0.2 1 11 0.05 0.05
2000 5,733 98 24.2 20.5 442 1,161 4.9 4.2 56 12 0.2 0.3 5 23 0.10 0.10
2001 7,010 80 29.4 24.4 561 1,209 5.1 4.2 45 3 0.2 0.2 2 17 0.07 0.08
2002 7,718 87 32.2 26.2 585 1,360 5.7 4.6 53 8 0.2 0.2 2 19 0.08 0.08
Total 49,558 1,786 21.4 19.0 2,984 10,402 4.5 4.0 406 62 0.2 0.2 15 142 0.06 0.07
Table 1. Beast cancer incidence and mortality 1993-2002 in Korea
DCO, Death Certificate Only cases; CIS, Carcinoma in situ.
*Incidence rate: (A)+(B)/100,000 population; 
�
Mortality rate: deaths/100,000 population.Breast Cancer Statistics in Korea 1993-2002 S13
of age to compare survival with those of other population,
relative survival was truncated for the 0-74 yr age group and
standardized to the standard cancer patient population (8).
For calculating stage-specific survival rates, 24,447 cases with
valid stage information were analyzed; 1,214 cases for stage
0, 6,445 cases for stage I, 13,116 cases for stage II, 2,978
cases for stage III, the 694 cases for stage IV following the
American Joint Committee on Cancer 5th edition for stag-
ing (9). The registered cases whose cause of death was breast
cancer were ascertained through the NSO, Ministry of Gov-
ernment Administration and Home Affairs, and the NHIC.
Observed survival rates (OSR) were calculated using a Life
table method, and relative survival rates (RSR) were exam-
ined by the Ederer II method (10) using an algorithm writ-
ten in SAS by Paul Dickman (11) with some minor adapta-
tions. The RSR confidence limits were derived by dividing
the observed survival limits by the corresponding expected
survival rate. To examine temporal trends, only cases diag-
nosed during 1993-1999 were analyzed, which were followed
up for complete 5 yr.
RESULTS
Incidence & Mortality
Among women, crude and age-standardized incidence and
mortality rates using world standard population per 100,000
are presented in Table 1. Average APC of female invasive
breast cancer incidence rates standardized to Korea 2000
standard population was 7.2% (p=0.002) from 1993 to 2002.
CIS generally increased in women during the period (Fig. 1A).
Age-specific incidence rates increased with age up to the 45-
49 age group and leveled off at ages above that in women.
Fig. 1. Incidence trends of female breast cancer in 1993-2002. (A) Incidence trends of female invasive breast cancer and CIS by year of
diagnosis. (B) Age-specific incidence rates of female invasive breast cancer by time period of diagnosis.
CIS, Carcinoma in situ; CR, Crude rate; ASR, Age-standardized rate using WHO world standard population.
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Fig. 2. Mortality trends of female breast cancer in 1993-2002. (A) Mortality trends of female breast cancer by year, (B) Age-specific mor-
tality rates of female breast cancer by time period of death.
AS, Age-standardized using WHO world standard population.
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Generally, peak incidence rates increased with time during
1993 and 2002 (Fig. 1B). Average APC of female invasive
breast cancer mortality rates was 2.3% during the period,
which was not significant (Fig. 2A). Age-specific mortality
rates in women showed peaks in the 50-59 age group throu-
ghout the period and increased after the age of 60-69 (Fig.
2B). In men, the total number of incidence in Korea during
the period of 1993-2002 was 406, which made a male-to-
female ratio for breast cancer incidence 1:122 (406:49,558)
during this period. Age-standardized incidence rates for men
ranged from 0.2 to 0.3 per 100,000, and there was no visi-
ble trend during the period in either incidence or mortality
possibly due to the limited number of cases. Although the
overall incidence remain- ed low, age-specific incidence rates
in men showed an increase with advancing age (Fig. 3). The
quality indices of cancer incidence DB are summarized in
Table 2. DCO%, especially of female invasive breast cancer
kept decreasing from 9.9% in 1993 to 1.1% in 2002. MV%
has been steadily increased from 84.0% in 1993 to 96.9%
in 2002. The M:I ratio decreased during the period. There
were no age-or sex-unknown cases.
Survival rates for invasive female breast cancer
For survival analysis, only female cases were included. Me-
dian follow-up time was 55 months. Five-year OSR and RSR
for invasive breast cancer diagnosed during 1993-2002 were
80.2% (95% CI 79.8, 80.6) and 82.2% (95% CI 81.8, 82.6),
respectively, and age-standardized 5-yr RSR were 76.8%
(95% CI 73.7, 81.2) for all ages and 81.0% (95% CI 79.9,
83.2) for the 0-74 age group. Five-year survival increased
steadily from 1993 to 1999 (Fig. 4). Survival was highly
dependent on the stage at diagnosis. Stage II was most com-
mon (53.6% on average) during the whole period. The pro-
portion of early breast cancer (CIS and stage I) increased from
24.2% in 1993 to 36.6% in 2002 and showed the highest
5-yr RSR (Fig. 5). 
Fig. 3. Age-specific incidence rates for male invasive breast can-
cer by time period of diagnosis.
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MV, Microscopically verified; DCO, Death certificate only; M:I, Mortality:
Incidence ratio.
Female
Year
DCO MV M:I
Male
DCO MV M:I
1993 9.9 82.9 25.3 4.8 85.7 14.3
1994 8.2 85.0 25.2 6.3 78.1 25.0
1995 7.3 86.4 26.3 32.0 68.0 64.0
1996 5.4 90.0 24.2 23.3 76.7 46.7
1997 4.1 91.1 21.6 12.2 83.7 24.5
1998 3.2 92.8 20.8 30.3 63.6 48.5
1999 2.0 94.2 20.1 9.8 85.4 26.9
2000 1.7 94.4 20.3 21.4 75.0 41.1
2001 1.1 95.8 17.2 6.7 88.9 37.8
2002 1.1 96.3 17.6 15.1 84.9 35.9
Total 3.6 92.1 21.0 15.3 80.0 35.0
Table 2. Quality indices of female invasive cancer DB by year
of diagnosis                                                                       (Unit: %)
1993 1994 1995 1996 1997 1998 1999
Fig. 4. Trends of observed and relative 5-yr survival rates for fe-
male invasive breast cancer diagnosed during 1993-1999.
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Fig. 5. Stage-specific 5-yr relative survival rates for female inva-
sive breast cancer and CIS diagnosed during 1993-2002.
CIS, Carcinoma in situ.
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This is the first report, that examined breast cancer trends
over a decade based on population-based data in Korea. Al-
though breast became the most common cancer site in Kore-
an women in 2002, the level of breast cancer incidence in
Korean women is considered as being modest when com-
pared with other countries’ incidences reported in the Globo-
can 2002. ASR per 100,000 Korean women in 2002 was
lower than the world average (26.2 vs. 37.4) and lower than
that of Japan (32.7), which is thought to have similar ethnic
background (1). In terms of the age-specific incidence pat-
tern, the rates showed a peak around the perimenopausal pe-
riod, which was also found in Japan and Taiwan. This pat-
tern is different from in Western countries, whose age-spe-
cific rates increased sharply up to the ages of menopause, but
at a slower rate above that age (12, 13). The median age at
diagnosis of invasive cancer in Korean women was 46 yr,
which almost did not change during the 10-yr period. How-
ever, average APC for incidence rates standardized to Korea
2000 population was 7.2% in women. It seems to be much
higher than those of European countries, which ranged from
0.8% to 3.0%, even after considering the use of different
standard population (14). This increase might be caused partly
by changes in previously known risk factors such as early
menarche, late menopause, and late first-delivery (15, 16).
However, it is more likely to reflect increasing completeness
of registration.
The breast cancer mortality rate was the 5th highest in
Korean women in 2004 (5). Korean women still have rela-
tively low breast cancer mortality rates than any other coun-
tries (4.6 vs. 13.2 per 100,000), and there was no significant
increase or decrease during the period (1). Age-specific mor-
tality rates of female invasive breast cancer seem to be differ-
ent from age-specific incidence rates. Considering there was
no significant difference in the distribution of disease stage
between age groups (data not shown), this might reflect that
cause of death for a large proportion of patients could be as-
signed as other competing diseases. For age-specific mortality
curves, only deaths from breast cancer were considered.
Survival rates of Korean female breast cancer were report-
ed as 2nd highest (5-yr RSR 77.5%), only second to thyroid
cancer (95.1%) (17). Compared with survival of other devel-
oping countries using age-standardized 5-yr RSR, our survi-
val is slightly lower than that of Hong Kong, China (82.5%),
but higher than those of Turkey (77.2%), Singapore (76.4%),
Thailand (62.9%), and India (51.6%) (18). For European
countries, from EUROCARE-3 study, age-standardized 5-
yr RSR for Europe, based on 256,464 female breast cancer
patients diagnosed during 1990-1994 from 22 European
countries, was 76.1% (19), which is similar to that of Korea
during 1993-1997. However, there is almost a 5-yr gap in
terms of the diagnosis period between these, which needs to
be taken into consideration. In our study, when the study
period was split into two (1993-1997 vs. 1998-2002) for
comparing the survival experience during the period, 5-yr
RSR during the latter period (84.3%, 95% CI 83.8, 84.8)
is higher than that (79.1%, 95% CI 78.5, 79.8) of the for-
mer period by 5.4%. It is very likely that the survival of these
European countries improved during those 5 yr as our survi-
val did during the study period. Also, using crude 5-yr RSR
among American women diagnosed during 1996-2002, sur-
vival (89.0%) (7) is higher than that of Korea during 1998-
2002. The five-year RSR of breast cancer among Japanese
women diagnosed during 1993-1996 was 83% (20), which
was higher than that of Korea during the similar period. How-
ever, we should interpret these results with great caution,
since there are differences in the diagnosis period and stan-
dardization methods among populations. For stage-specific
survival, 50.4% (24,867 out of 49,304 cases) of cases were
excluded due to missing stage information. There is a differ-
ence in overall 5-yr RSR between cases with stage informa-
tion and cases without by 9.8%; 87.2% (95% CI 86.6, 87.7)
vs. 77.4% (95% CI 76.8, 78.0). We checked the systematic
differences between staged and un-staged cases using other
available information such as the mean age at diagnosis, treat-
ment (operation/non-operation), and residential areas (data
not shown). We found that the proportion of staged cases
was increasing during the study period, which could repre-
sent cases with more favorable prognosis with time. Also sur-
gical treatment was more common in staged patients. This
phenomenon was observed previously and been interpreted
that stages of who had not undergone surgery were more
likely to be advanced than cases with stage information, which
could cause the worse overall survival in un-staged cases (21).
Completeness is an important issue in calculating and
interpreting cancer incidence, which we checked indirectly
using DCO% and M:I ratio (22). However, DCO% itself is
not an indicator of completeness, with elevated DCO% being
suggestive of incompleteness. DCO%, especially of female
invasive breast cancer, kept decreasing from 9.9% in 1993
to 1.1% in 2002 (2). It made very difficult to interpret the
secular trends of incidence, and the estimated APC is very
much likely to be overestimated. The M:I ratio has been de-
creased, which suggested improved completeness of incidence
DB and correctly reflected the changing pattern of survival
during the period at the same time. Especially, an ad hoc me-
dical record review survey covering data registered from 1999
has been performed since 2001, which increases complete-
ness. Another important aspect of registry data is validity,
which we checked using MV%. MV% has been steadily in-
creased from 84.0% in 1993 to 96.9% in 2002. 
For survival analysis, we achieved nearly 100% follow-up
through the PIN, used in Korea, which is given at the time
of birth and contains information about sex, date, and place
of birth. The accuracy of cause of death for breast cancer was
reported to be very high (23), and the proportion of cause of
death certified by doctors has increased up to 86.5% (24) in
Breast Cancer Statistics in Korea 1993-2002 S152005. Additionally, cause of death has become more accu-
rate and complete by collaboration between KCCR and NSO
since 2000.
In summary, the female breast cancer incidence in Korea
seems to have been increasing, which is possibly due to the
combined effects of various factors including completeness of
registry data, population aging, and changes in risk factors.
Contributing factors should be identified by further studies,
which will enable to interpret the registry data properly and
to plan effective protective measures. It is also necessary to
examine the factors related to improved survival including
patient characteristics, disease stage, and treatments. This
report will be valuable as baseline data to plan and evaluate
actions against breast cancer including evaluating the nation-
al breast cancer screening program.
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